Randomised clinical trial: faecal microbiota transplantation versus autologous placebo administered via colonoscopy in irritable bowel syndrome
Open Access
- 28 April 2020
- journal article
- research article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 51 (12), 1321-1331
- https://doi.org/10.1111/apt.15740
Abstract
Background Irritable bowel syndrome (IBS) has been associated with microbial dysbiosis. Aim To investigate the efficacy of faecal microbiota transplantation (FMT) in the treatment of IBS. Methods Forty‐nine IBS patients were randomised to receive autologous or allogenic FMT via colonoscopy. The primary endpoint was a sustained, minimum of 50‐point, reduction in the IBS Symptom Severity Score. The secondary outcomes were levels of anxiety and depression, changes in quality of life, gut microbiota and faecal water content as assessed with validated questionnaires, intestinal microbiota composition and stool dry weight. Results The primary endpoint was not achieved in either group. However, there was a transient reduction in the mean IBS Symptom Severity Score in the FMT group at 12 weeks after treatment as compared to baseline (P = 0.01). The groups did not differ in the number of patients achieving clinical response at 12 weeks. In the FMT‐treated patients, microbial composition had changed to resemble that of the donor and the stool water content decreased significantly compared to baseline. The depression score decreased in patients with a reduction in IBS symptoms after FMT, but not in those placebo‐treated patients who experienced a reduction in IBS symptoms. Conclusions FMT provided only a transient relief of symptoms, although it induced a sustained alteration in the microbiota of IBS patients. Therefore, FMT delivered by a single infusion via colonoscopy cannot be recommended as a treatment for IBS in clinical practice. ClinicalTrials.Org, Trial registration number: NCT03561519.Keywords
Funding Information
- Finnish Academy (0313471-7)
- the Competitive State Research Financing (200230042)
- Sigrid Juselius Foundation
This publication has 47 references indexed in Scilit:
- Anxiety and depression comorbidities in irritable bowel syndrome (IBS): a systematic review and meta-analysisArchiv Fur Psychiatrie Und Nervenkrankheiten, 2014
- Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndromeGut, 2013
- Validation of the Rome III Criteria for the Diagnosis of Irritable Bowel Syndrome in Secondary CareGastroenterology, 2013
- Fecal Transplantation, Through Colonoscopy, Is Effective Therapy for Recurrent Clostridium difficile InfectionGastroenterology, 2012
- Gastrointestinal Microbiome Signatures of Pediatric Patients With Irritable Bowel SyndromeGastroenterology, 2011
- Intestinal Microbiota in Healthy Adults: Temporal Analysis Reveals Individual and Common Core and Relation to Intestinal SymptomsPLOS ONE, 2011
- Comparative analysis of fecal DNA extraction methods with phylogenetic microarray: Effective recovery of bacterial and archaeal DNA using mechanical cell lysisJournal of Microbiological Methods, 2010
- Health-related quality of life in inflammatory bowel disease measured with the generic 15D instrumentQuality of Life Research, 2010
- Gastrointestinal complaints among subjects with depressive symptoms in the general populationAlimentary Pharmacology & Therapeutics, 2008
- Suppression of experimental colitis by intestinal mononuclear phagocytesJournal of Leukocyte Biology, 2006